ESEF — Europäische Jahresabschlüsse (iXBRL) fact · reporting period
ABIONYX PHARMA: ifrs:FinanceIncomeCost
One fact, its scope and the complete path back to the official record.
Reported value
-106.000k{"amount": -106000.0}- Entity
- ABIONYX PHARMA
- Metric
- ifrs:FinanceIncomeCost
- Period
- 2023-01-01 – 2023-12-31
- Status
- current
- Source
- ESEF — Europäische Jahresabschlüsse (iXBRL)
Provenance
Official reference
esef:969500785J7VIC5YPC96:2023-12-31Source licensePublic filings (ESEF-Verordnung)
Retrieved2026-08-23T23:53:14.801477+02:00
Raw response SHA-256
84cd09b5a9c076cfbfc26f8b51663071…History
- no predecessors — first report
Why this page exists
The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.